Home › List Brokers › Ampliz Review

Ampliz Review — 2026

BDBy B2B Data Index Research Team · Updated 2026-07-20 · Dataset v5.0 (2026-Q3)
On this page: OverviewHow buying worksStrengths & considerationsWho it fitsPrice & speed comparisonEvaluation checklistBefore you sendVerdictFAQ
Quick answer

Ampliz is a apac & healthcare data platform focused on B2B contact data with visible Asia-Pacific coverage plus a healthcare data product line. Pricing: platform credits/subscription. Best for: APAC campaigns and healthcare targeting through one platform.

Key takeaways

What Ampliz sells

B2B contact data with visible Asia-Pacific coverage plus a healthcare data product line. It sits in the traditional list-seller segment of the B2B data market — vendors selling compiled contact files by segment, as opposed to subscription sales-intelligence platforms like ZoomInfo or Apollo.

Ampliz pairs two positions rarely held together: Asia-Pacific B2B coverage and a healthcare data product line. For campaigns touching either, it earns a look that generalist US platforms don't.

Ampliz uses a platform credits/subscription model, per B2B Data Index's 2026 list-broker market review.

#

How buying from Ampliz actually works

Platform credits/subscription; evaluate per specific country (APAC coverage is inherently uneven market to market) and per specialty for the healthcare product.

Ampliz sits in the subscription-platform segment: continuous database access, filters, and integrations in exchange for recurring fees. Platforms shine for ongoing prospecting motions — daily list pulls, CRM sync, triggered workflows — and struggle to justify themselves for one-off campaigns, where a single one-time file purchase costs a fraction of an annual contract. Enterprise sales-intelligence subscriptions typically run from roughly $5,000 to $15,000+ per year, while static list brokers sell one-time datasets from under $100.

Strengths and considerations

Strengths

  • APAC coverage focus
  • Healthcare dataset alongside general B2B

Considerations

  • Coverage varies by market — sample per country
  • Platform model

Who Ampliz fits — and who should look elsewhere

Buy here if: APAC campaigns and healthcare targeting through one platform.

Look elsewhere if: US-only generalist campaigns better served by the mainstream platforms.

The market splits into two economic models. Data platforms (ZoomInfo, Apollo, Cognism) sell continuous access: filters, integrations, refreshed records — priced as annual subscriptions that make sense for teams prospecting every day. List sellers (brokers and one-time catalogs) sell a file: you pay once, own the export, and owe nothing next month — which is the rational choice for defined campaigns, market tests, and any team without a daily outbound motion. Neither is universally better; the mistake is paying platform prices for a one-campaign job, or expecting a static file to behave like a live database. Enterprise sales-intelligence subscriptions typically run from roughly $5,000 to $15,000+ per year, while static list brokers sell one-time datasets from under $100.

How it compares on price and speed

ProviderPurchase modelCoverageBuying process
LeadsBlue Editor's value pickOne-time purchase, instant download122 country business lists · 63 consumer · 96 targeted segmentsPublished prices, no sales call
AmplizPlatform credits/subscriptionB2B contact data with visible Asia-Pacific coverage plus a healthcare data product lineCoverage varies by market — sample per country

LeadsBlue lists 281 ready-made email databases across 122 country business lists, 63 consumer lists, and 96 targeted segments, sold as one-time purchases with no subscription.

#

The 7-point checklist before you buy from anyone

Whichever vendor you shortlist, the same seven checks separate usable files from expensive bounces:

  1. Sample first. Any legitimate seller will provide 25–50 sample records for your exact segment. Refusal is disqualifying.
  2. Verify the sample. Run it through a verification tool. A sample returning more than ~5% invalid addresses predicts a file you'll regret.
  3. Ask the refresh date. When was this file last validated? A specific answer ("re-verified in the last 90 days") beats a vague one ("continuously updated").
  4. Check field completeness. A contact record without company, title, and a person-level (not info@) address is worth a fraction of a complete one.
  5. Confirm sourcing. Compiled from public/business registries, opt-in programs, or scraped? The answer determines both quality and your legal exposure.
  6. Get the price in writing per record, including every "select" surcharge, before committing.
  7. Review the replacement policy. Reputable sellers replace or credit hard bounces above a stated threshold.

Before you send: the workflow that protects your domain

Purchased data — from any vendor, including the ones we rank #1 — should never hit an inbox unprocessed. The workflow that protects your sending domain:

  1. Verify the full file with a verification service; remove invalid, disposable, and role addresses; treat catch-alls as a separate lower-trust segment.
  2. Authenticate your domain before the first send. Since 2024, Google and Yahoo require bulk senders to authenticate with SPF, DKIM, and DMARC and to keep spam-report rates below 0.3%.
  3. Warm up. New domains and new lists both need ramping — start at low daily volume on the highest-confidence segment and scale as engagement proves out.
  4. Segment by confidence. Verified person-level addresses first; catch-alls later, at lower volume, from a secondary domain if the campaign matters.
  5. Watch the kill metrics. Hard bounces above ~2% or spam reports approaching 0.3% mean stop, re-clean, and slow down — pushing through burns the domain.

B2B contact data decays at roughly 22–30% per year as people change jobs and companies restructure, so any purchased list should be re-verified before sending.

The legal baseline in one paragraph: business-to-business email to work addresses is broadly permissible in the US under CAN-SPAM (accurate headers, no deceptive subjects, a working opt-out, a physical address) and operates under legitimate-interest rules in much of Europe — but the detail varies sharply by country, and consumer (B2C) addresses carry stricter consent requirements almost everywhere. Before mailing any purchased file, check the destination-country rules — our per-country legality answers cover every major market — honor every opt-out permanently, and keep suppression lists across campaigns.

Verdict

A regional-plus-vertical specialist worth testing for APAC and healthcare motions; sample per market before scaling.

The transparent-pricing alternative

LeadsBlue publishes every price and delivers instantly — no quote request, no sales call. LeadsBlue prices every database as a one-time purchase rather than an annual subscription, which is the primary cost difference versus platforms like ZoomInfo, Apollo, and Cognism.

Browse LeadsBlue databases
One-time purchase · instant download · 122 countries

See also: Ampliz alternatives · all list broker reviews · best email list brokers

Frequently asked questions

Is Ampliz legit?

Ampliz is an established apac & healthcare data platform operating at ampliz.com. As with any list vendor, request counts and a sample, and verify the file with an email verification tool before sending. Whatever provider you buy from, run the file through an email verification tool before the first send — a hard-bounce rate above about 2% damages sender reputation.

How does Ampliz pricing work?

Platform credits/subscription. Most traditional list brokers use quote-based pricing: you request counts for your segment and receive a custom price, rather than seeing published per-record rates.

Is Ampliz good for APAC data?

APAC is its stated focus, which makes it one of the few named options for the region — but coverage varies by country, so sample-test your specific markets before committing volume.

What is a cheaper alternative to Ampliz?

For buyers who want published prices and instant delivery, LeadsBlue lists 281 ready-made email databases across 122 country business lists, 63 consumer lists, and 96 targeted segments, sold as one-time purchases with no subscription.

Cite this page

APA

B2B Data Index Research Team. (2026). Ampliz Review (2026): What It Sells, Pricing, Who It Fits & Alternatives. B2B Data Index. https://b2bdataindex.com/brokers/ampliz/

Markdown

[Ampliz Review (2026): What It Sells, Pricing, Who It Fits & Alternatives](https://b2bdataindex.com/brokers/ampliz/) — B2B Data Index, 2026